GEORGIOU GEORGE 4
4 · Aeglea BioTherapeutics, Inc. · Filed Dec 5, 2017
Insider Transaction Report
Form 4
GEORGIOU GEORGE
Director
Transactions
- Award
Director Stock Option (right to buy)
2017-12-01+30,000→ 30,000 totalExercise: $4.73Exp: 2027-11-30→ Common Stock (30,000 underlying)
Footnotes (1)
- [F1]The stock option vests and becomes exercisable in 12 equal monthly installments beginning on January 1, 2018 until such time as the option is 100% vested, subject to the continuing service of the Reporting Person on each vesting date.